Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
Clinical trial NCT06690840 · RECRUITING
Trial details
- NCT number
- NCT06690840
- Sponsor
- European Institute of Oncology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-06
- Primary completion
- 2026-12-15
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.